MedElevator Войти в исследования
← Поиск публикаций

DOI 10.3747/pdi.2014.00029

Медицинская библиотека · Peritoneal dialysis international : journal of the International Society for Peritoneal Dialysis · 2014

Peritoneal Dialysis Can Be an Option for Dominant Polycystic Kidney Disease: an Observational Study.

Janeiro Darío, Portolés Jose, Tato Ana María, López-Sánchez Paula, Del Peso Gloria, Rivera Maite, Castellano Inés, Fernández-Reyes Maria J, Pérez-Gómez Vanessa, Ortega Mayra, Martínez-Miguel Patricia, Felipe Carmen, Caparrós Guadalupe, Ortiz Alberto, Selgas Rafael, Grupo Centro de Diálisis Peritoneal (GCDP)

СтатьяМногоцентровое исследованиеНаблюдательное исследованиеПоддержка исследования: вне правительства СШАПеревод в очереди

Аннотация

BACKGROUND

Autosomal dominant polycystic kidney disease (ADPKD) has been considered a relative contraindication for peritoneal dialysis (PD), although there are few specific studies available.

METHODS

A multicenter historical prospective matched-cohort study was conducted to describe the outcome of ADPKD patients who have chosen PD. All ADPKD patients starting PD (n = 106) between January 2003 and December 2010 and a control group (2 consecutive patients without ADPKD) were studied. Mortality, PD-technique failure, peritonitis, abdominal wall leaks and cyst infections were compared.

RESULTS

Patients with ADPKD had similar age but less comorbidity at PD inclusion: Charlson comorbidity index (CCI) 4.3 (standard deviation [SD] 1.6) vs 5.3 (SD 2.5) p < 0.001, diabetes mellitus 5.7% vs 29.2%, p < 0.001 and previous cardiovascular events 10.4% vs 27.8%, p < 0.001. No differences were observed in clinical events that required transient transfer to hemodialysis, nor in peritoneal leakage episodes or delivered dialysis dose. The cyst infection rate was low (0.09 episodes per patient-year) and cyst infections were not associated to peritonitis episodes. Overall technique survival was similar in both groups. Permanent transfer to hemodialysis because of surgery or peritoneal leakage was more frequent in ADPKD. More ADPKD patients were included in the transplant waiting list (69.8 vs 58%, p = 0.04) but mean time to transplantation was similar (2.08 [1.69 - 2.47] years). The mortality rate was lower (2.5 vs 7.6 deaths/100 patient-year, p = 0.02) and the median patient survival was longer in ADPKD patients (6.04 [5.39 - 6.69] vs 5.57 [4.95 - 6.18] years, p = 0.024).

CONCLUSION

Peritoneal dialysis is a suitable renal replacement therapy option for ADPKD patients.

Для цитирования: Janeiro Darío, Portolés Jose, Tato Ana María, López-Sánchez Paula, Del Peso Gloria, Rivera Maite, Castellano Inés, Fernández-Reyes Maria J, Pérez-Gómez Vanessa, Ortega Mayra, Martínez-Miguel Patricia, Felipe Carmen, Caparrós Guadalupe, Ortiz Alberto, Selgas Rafael, Grupo Centro de Diálisis Peritoneal (GCDP). Peritoneal Dialysis Can Be an Option for Dominant Polycystic Kidney Disease: an Observational Study.. Peritoneal dialysis international : journal of the International Society for Peritoneal Dialysis. 2014. DOI: 10.3747/pdi.2014.00029.

Предметные рубрики MeSH

Подготовка и перевод публикации
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…

История · было → стало

Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.

Тип публикации указан по данным источника. Уровень доказательности автоматически не присваивается.